Search results
Annie F. Luetkemeyer is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco. She specializes in infectious diseases, in particular tuberculosis, human immunodeficiency virus and viral hepatitis.
Annie Luetkemeyer is a clinical professor of HIV, infectious disease, and global medicine at UCSF. She has expertise in HIV therapeutic strategies, COVID-19 treatment and prevention, and viral hepatitis.
Annie Luetkemeyer is a professor of medicine at UCSF and an expert in HIV, COVID-19, and sexually transmitted infections. She has published numerous papers on these topics and leads clinical trials at SFGH and other sites.
- 1001 Potrero Avenue, #4904 San Francisco CA
- Professor, Medicine
- (415) 502-5753
Annie Luetkemeyer is a professor at the School of Medicine of the University of California, San Francisco. She studies the microbiome and its role in infectious diseases, such as hepatitis C, COVID-19, and tuberculosis.
Annie Luetkemeyer, MD, is a UCSF infectious disease physician and researcher who leads clinical trials of promising therapies for COVID-19, including remdesivir and convalescent plasma. She also cares for HIV and hepatitis C patients and advocates for vulnerable populations affected by the pandemic.
Annie Luetkemeyer is a professor of clinical medicine at UCSF and a specialist in HIV/AIDS and TB coinfection. She directs the HIV Clinical Trials Group at SFGH and has published on various topics related to HIV, TB, hepatitis C, and COVID-19.
The UCSF-Bay Area Center for AIDS Research (CFAR) and this website are funded by the National Institutes for Health under grant number P30 AI027763 to the University of California, San Francisco.
Related searches
